---
title: "Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688393.SH.md"
symbol: "688393.SH"
name: "Guangzhou LBP Medicine Science & Technology Co., Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-20T09:10:54.009Z"
locales:
  - [en](https://longbridge.com/en/quote/688393.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688393.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688393.SH.md)
---

# Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SH)

## Company Overview

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridization instruments; fluorescence in situ hybridization products comprising auto-fish instruments, and AML1/ETO, EGFR, BCR/ABL fusion, PML/RARA, and TOP2A gene testing kits; and digital pathology products pathological medical image analysis processing systems, real-time microscopic visual field sharing systems, and bingli scanner. It also provides immunohistochemistry products including automatic antigen repair instrument and automatic immunocytochemical staining machine, as well as conversional pathology equipment.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.gzlbp.com](https://www.gzlbp.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: D (0.62)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 64 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -20.46% |  |
| Net Profit YoY | -1789.09% |  |
| P/B Ratio | 1.97 |  |
| Dividend Ratio | 0.40% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2327418407.73 |  |
| Revenue | 352078061.26 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -3.11% | D |
| Profit Margin | -10.75% | D |
| Gross Margin | 67.23% | A |
| Revenue YoY | -20.46% | E |
| Net Profit YoY | -1789.09% | E |
| Total Assets YoY | -5.23% | D |
| Net Assets YoY | -5.11% | D |
| Cash Flow Margin | -45.80% | E |
| OCF YoY | -20.46% | E |
| Turnover | 0.27 | D |
| Gearing Ratio | 8.14% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Guangzhou LBP Medicine Science & Technology Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-20.46%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-1789.09%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.97",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.40%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "2327418407.73",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "352078061.26",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-3.11%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-10.75%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "67.23%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-20.46%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-1789.09%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-5.23%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-5.11%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-45.80%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-20.46%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.27",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "8.14%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -61.47 | 60/64 | 1313.08 | 1232.79 | 1188.47 |
| PB | 1.97 | 14/64 | 2.22 | 2.03 | 1.86 |
| PS (TTM) | 6.61 | 35/64 | 6.78 | 6.32 | 6.00 |
| Dividend Yield | 0.40% | 43/64 | 0.42% | 0.38% | 0.34% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688393.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688393.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688393.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**